New pouch aims to make mealtimes safer for Huntington's patients
NCT ID NCT07299682
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study was designed to test whether a reusable pouch called DoddleBags could help people with Huntington's disease eat more easily and safely. The pouch holds pureed food and can be used with an anti-choking cap or spoon attachment. The trial was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- DoddleBags (reusable flexible pouches for pureed food)
- What this could lead to
- If successful, DoddleBags could offer a simple, practical tool to help people with Huntington's disease feed themselves more easily and reduce choking risks.
- What could go wrong
- The study was withdrawn before enrolling any participants, so no data was collected. The device may not work for everyone or may not improve eating behaviors as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Started
-
Nov 2024
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Aged 18 or over at the time of recruitment. Genetic confirmation of the HD gene expansion, defined as a CAG repeat length of ≥40 CAG repeats on the long allele. Chorea, uncontrollable bodily movements, to the extent that it, in the opinion of the participant, inhibits normal or typical use of an eating utensil such as a fork or spoon. AND/OR Cognitive issues that make it impractical for the participant to engage in self-feeding behaviours in a safe and effective manner, perhaps but not necessarily requiring the input of a carer or companion to feed the participant. Exclusion Criteria: Failing to meet the inclusion criteria. The presence of a pre-existing neurological or movement disorder that could mimic, mask, or otherwise occlude the symptoms of Huntington's Disease. Current use of DoddleBags as a feeding aid outside of this research. Ability to regularly self-feed in a safe and effective manner rendering the integration of DoddleBags into one's lifestyle moot. Use of a mandated/recommended diet that would be incompatible with DoddleBags, such as mandated use of non-pureed or non-soft foods. Inability or unwillingness to engage with any specific aspects of the research, including completion of the food diaries, interviews or questionnaires, as well as being unable to provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Huntington'S disease (HD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cambridge University Hospitals
Cambridge, United Kingdom
-
Cardiff University
Cardiff, United Kingdom
-
Leeds Teaching Hospitals
Leeds, United Kingdom
-
Leicestershire Partnership NHS Trust
Leicester, United Kingdom
-
NHS Greater Glasgow & Clyde
Glasgow, United Kingdom
-
Sheffield Children's Hospital
Sheffield, United Kingdom
-
Walton Centre NHST
Liverpool, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain scan tracer could reveal hidden signs of psychosis in Parkinson's
- Hope for Huntington's: new drug aims to slow decline in major trial
- New hope for Huntington's patients: drug eases involuntary movements
- Experimental drug aims to curb disinhibition in dementia patients
- New drug SRP-1005 takes first step against Huntington's
- Can video games help Huntington's patients move and think better?